- Recent Funding
- Investors
- Scientific Health Development Partners
Scientific Health Development Partners portfolio
Scientific Health Development Partners has 1 portfolio company on record at Recent Funding.
About this page
Its most recent investment on record is Koya Medical's $26M Series B+ round in February 2022, alongside 3×5 Partners, Arboretum Ventures, Asahi Kasei Corporate Venture Capital and 1 other. That company is in Health and bio.
What Scientific Health Development Partners invests in
- Health and bio · 1 · 100%
How Scientific Health Development Partners invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series B+ | 1 100% | $26M |
Scientific Health Development Partners portfolio companies
KKoya Medical$26MSeries B+ · Feb 2022
| Company | Round with Scientific Health Development Partners | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series B+ · $26M | $56M | Nov 15, 2023 round |
Most frequent co-investors
AArboretum Ventures1 shared round · last Feb 3, 2022
AAsahi Kasei Corporate Venture Capital1 shared round · last Feb 3, 2022
33×5 Partners1 shared round · last Feb 3, 2022
CCadence Healthcare Ventures1 shared round · last Feb 3, 2022
Similar investors
AAvant Bio1 company · 1 deal in 12 mo
BBiospring Partners1 company · 1 deal in 12 mo
CColossa Ventures1 company · 1 deal in 12 moCCommerzbank1 company · 1 deal in 12 mo
CCultivian Sandbox Ventures1 company · 1 deal in 12 mo
FFiducia1 company · 1 deal in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Scientific Health Development Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Scientific Health Development Partners, which is a subset of its real portfolio. API: /api/v1/investors/scientific-health-development-partners (get a free API key). More: the most active VC firms and new venture capital funds.